GlassScriptPhysician profile
David A Hampton
NPI 1255348694
$4,488.14
in general payments reported to CMS, 2019-2025
13 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $168 · 2021: $25.95 · 2022: $1,390 · 2023: $1,452 · 2024: $861 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199 · Travel and Lodging: $418.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.82 |
| Travel and Lodging | $417.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,269.20 | 2020-2022 | |
| Supreme Orthopedic Systems, LLC | $1,112.15 | 2022-2023 | |
| Kerecis Limited | $709.44 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Teleflex LLC | $257.29 | 2023-2025 | Quikclot, Quikclot |
| Haemonetics Corporation | $216.99 | 2023 | Teg6s Hemostasis System |
| Prytime Medical Devices, INC. | $200.70 | 2019 | |
| Avita Medical Americas, LLC | $138.27 | 2024 | |
| Baxter Healthcare | $136.61 | 2024 | Starling System |
| Polynovo North America LLC | $131.80 | 2022 | |
| Atricure, INC. | $90.58 | 2023 | |
| Merck Sharp & Dohme LLC | $87.14 | 2019 | |
| Bioventus LLC | $84.40 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Acell, INC. | $53.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.